High serum levels of interleukin-6 in patients with advanced or metastatic colorectal cancer: the effect on the outcome and the response to chemotherapy plus bevacizumab

Purpose We evaluated the relationship of the pretreatment serum IL-6 levels with the outcome and treatment response in patients with advanced or metastatic colorectal cancer (CRC) who underwent bevacizumab-containing chemotherapy. Methods In this retrospective study, the pretreatment serum IL-6 and...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Surgery today (Tokyo, Japan) Japan), 2017-04, Vol.47 (4), p.483-489
Hauptverfasser:	Hara, Masayasu, Nagasaki, Takaya, Shiga, Kazuyoshi, Takahashi, Hiroki, Takeyama, Hiromitsu
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab - administration & dosage Biomarkers, Tumor - blood Colorectal Neoplasms - diagnosis Colorectal Neoplasms - drug therapy Colorectal Neoplasms - mortality Colorectal Neoplasms - secondary Female Follow-Up Studies Humans Interleukin-6 - blood Male Medicine Medicine & Public Health Middle Aged Neoplasm Staging Original Article Retrospective Studies Risk Factors ROC Curve Surgery Surgical Oncology Survival Rate Time Factors Treatment Outcome Vascular Endothelial Growth Factor A - blood
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!